[Clinical study on the pharmacokinetics of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001711:Biotransformation; D002247:Carbon Isotopes; D003998:Dicarboxylic Acids / Q000008:administration & dosage / Q000378:metabolism; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D009060:Mouth Floor; D009578:Nitrobenzenes / Q000008:administration & dosage / Q000378:metabolism*; D011725:Pyridines / Q000008:administration & dosage / Q000378:metabolism*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000378:metabolism*
D002247:Carbon Isotopes; D003998:Dicarboxylic Acids; D009578:Nitrobenzenes; D011725:Pyridines; D014665:Vasodilator Agents
Klinische Untersuchungen zur Pharmakokinetik von radioaktiv markiertem 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester.